Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

126.62
Delayed Data
As of 4:00pm ET
 -0.92 / -0.72%
Today’s Change
87.50
Today|||52-Week Range
129.94
+24.61%
Year-to-Date

Today’s Trading

Previous close127.54
Today’s open126.80
Day’s range126.38 - 128.71
Volume334,778
Average volume (3 months)219,253
Market cap$2.7B
Dividend yield--
Data as of 4:00pm ET, 08/17/2017

Growth & Valuation

Earnings growth (last year)-101.05%
Earnings growth (this year)+37.40%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+51.53%
P/E ratio333.2
Price/Sales19.42
Price/Book7.81

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co-1.26-3.44%
AGIOAgios Pharmaceutical...-1.33-2.37%
ICPTIntercept Pharmaceut...-1.28-1.21%
GWPHGW Pharmaceuticals P...-1.36-1.32%
Data as of 4:00pm ET, 08/17/2017

Financials

Last reporting dateAugust 7, 2017
EPS forecast (this quarter)$0.46
Annual revenue (last year)$109.0M
Annual profit (last year)-$2.4M
Net profit margin-2.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts